Project

Curevac RNA Laboratories Enlargement, Tübingen

With a single discovery, CureVac opened the world up to the potential of mRNA to treat diseases and create vaccines. Officially founded in 2000, CureVac is the world’s first company to successfully harness mRNA for medical purposes.

Year: 2021
Project location: Tübingen, Germany
Works:

Vetter Lufftechnik

  • KR16 Unit for 41000 m³/h , counterflow , MCB controlboard
curevac2_1668761213-71d7ec066300ebb63316ae861e4bba7c.png
curevac1_1668761213-7792a38edbabbb62c8968d10fcca86d3.png